These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33803899)

  • 41. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
    Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
    Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cardiovascular effect of the uremic solute indole-3 acetic acid.
    Dou L; Sallée M; Cerini C; Poitevin S; Gondouin B; Jourde-Chiche N; Fallague K; Brunet P; Calaf R; Dussol B; Mallet B; Dignat-George F; Burtey S
    J Am Soc Nephrol; 2015 Apr; 26(4):876-87. PubMed ID: 25145928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uremic Toxin Clearance and Cardiovascular Toxicities.
    Mair RD; Sirich TL; Meyer TW
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
    Mishima E; Fukuda S; Kanemitsu Y; Saigusa D; Mukawa C; Asaji K; Matsumoto Y; Tsukamoto H; Tachikawa T; Tsukimi T; Fukuda NN; Ho HJ; Kikuchi K; Suzuki C; Nanto F; Suzuki T; Ito S; Soga T; Tomioka Y; Abe T
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F824-F833. PubMed ID: 29167170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Poesen R; Evenepoel P; de Loor H; Delcour JA; Courtin CM; Kuypers D; Augustijns P; Verbeke K; Meijers B
    PLoS One; 2016; 11(4):e0153893. PubMed ID: 27100399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain.
    El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S
    Pediatr Nephrol; 2021 Jun; 36(6):1589-1595. PubMed ID: 33387017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombosis in the uremic milieu--emerging role of "thrombolome".
    Shashar M; Francis J; Chitalia V
    Semin Dial; 2015; 28(2):198-205. PubMed ID: 24962903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
    Yang CY; Tarng DC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical association between the metabolite of healthy gut microbiota, 3-indolepropionic acid and chronic kidney disease.
    Sun CY; Lin CJ; Pan HC; Lee CC; Lu SC; Hsieh YT; Huang SY; Huang HY
    Clin Nutr; 2019 Dec; 38(6):2945-2948. PubMed ID: 30612852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.
    Kolachalama VB; Shashar M; Alousi F; Shivanna S; Rijal K; Belghasem ME; Walker J; Matsuura S; Chang GH; Gibson CM; Dember LM; Francis JM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2018 Mar; 29(3):1063-1072. PubMed ID: 29343519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
    Laville SM; Massy ZA; Kamel S; Chillon JM; Choukroun G; Liabeuf S
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.
    Moraes C; Fouque D; Amaral AC; Mafra D
    J Ren Nutr; 2015 Nov; 25(6):459-65. PubMed ID: 26235933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.